BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10681737)

  • 1. Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma.
    Bertero MT; De Maestri M; Caligaris-Cappio F
    Haematologica; 2000 Feb; 85(2):216-7. PubMed ID: 10681737
    [No Abstract]   [Full Text] [Related]  

  • 2. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
    Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
    AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
    [No Abstract]   [Full Text] [Related]  

  • 3. [Generalized Castleman's disease associated with Kaposi's sarcoma].
    Reverter JC; Nomdedeu B; Martín Ortega E; Llebaría C; Palou J; Rozman C
    Rev Clin Esp; 1988 Mar; 182(4):206-9. PubMed ID: 3413312
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicentric Castleman's disease in association with Kaposi's sarcoma.
    De Rosa G; Barra E; Guarino M; Gentile R
    Appl Pathol; 1989; 7(2):105-10. PubMed ID: 2730798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Kaposi's sarcoma associated herpesvirus-like DNA sequences (KSHV) in HIV-negative multicentric Castleman's disease complicated by KSHV-positive Kaposi's sarcoma.
    Kwong YL; Chan AC
    Br J Haematol; 1997 Mar; 96(4):881-2. PubMed ID: 9074443
    [No Abstract]   [Full Text] [Related]  

  • 6. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric Castleman's disease treated with antivirals and immunosuppressants.
    Senanayake S; Kelly J; Lloyd A; Waliuzzaman Z; Goldstein D; Rawlinson W
    J Med Virol; 2003 Nov; 71(3):399-403. PubMed ID: 12966545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
    Bestawros A; Boulassel MR; Michel RP; Routy JP
    J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
    [No Abstract]   [Full Text] [Related]  

  • 10. Kaposi's sarcoma of lymph nodes associated with multicentric angiofollicular hyperplasia.
    Leoncini L; del Vecchio MT; Minacci C; Pieragalli D; Monaci A
    Appl Pathol; 1989; 7(5):329-32. PubMed ID: 2635620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient.
    Gaitonde S; Vidanovic V; Ni H
    Histopathology; 2007 Jun; 50(7):954-8. PubMed ID: 17543090
    [No Abstract]   [Full Text] [Related]  

  • 12. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
    Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma.
    Dickson D; Ben-Ezra JM; Reed J; Flax H; Janis R
    Arch Pathol Lab Med; 1985 Nov; 109(11):1013-8. PubMed ID: 3840353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of Castleman's disease and Kaposi's sarcoma. Report of a case and a speculation.
    Rywlin AM; Rosen L; Cabello B
    Am J Dermatopathol; 1983 Jun; 5(3):277-81. PubMed ID: 6625119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric Castleman's disease: an emerging opportunistic infection.
    McCall J; Phillips JC
    J Assoc Nurses AIDS Care; 2013; 24(1):88-90. PubMed ID: 22564919
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease.
    Boivin G; Côté S; Cloutier N; Abed Y; Maguigad M; Routy JP
    J Med Virol; 2002 Nov; 68(3):399-403. PubMed ID: 12226828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.
    Barbarov I; Koren-Michowitz M; Schiby G; Portnoy O; Livingstone D; Segal G
    Isr Med Assoc J; 2015 Apr; 17(4):253-5. PubMed ID: 26040056
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaline vascular Castleman's disease: a case report and brief review of the literature.
    van den Berge M; Pauwels P; Jakimowicz JJ; Creemers GJ
    Neth J Med; 2002 Dec; 60(11):444-7. PubMed ID: 12685494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of lymphoproliferative disease associated with disseminated Kaposi's sarcoma].
    Koren W; Samra Y; Mani A; Shibi Z; Gur H
    Harefuah; 1996 Feb; 130(4):225-8; 296. PubMed ID: 8675110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.